In order to describe the expression pattern of the CIP2A/p-AKT signaling axis in breast cancer in more detail, and despite the lack of clinical impact in the luminal subgroup, we also investigated the expression levels of both CIP2A and p-AKT in luminal breast cancer cell lines such as MCF-7 and T47D. The gene discussed is AKT1; the disease is breast carcinoma.